{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T13:50:42Z","timestamp":1762005042631},"reference-count":21,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,7,21]],"date-time":"2018-07-21T00:00:00Z","timestamp":1532131200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nefrolog\u00eda"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1016\/j.nefro.2018.05.009","type":"journal-article","created":{"date-parts":[[2018,8,20]],"date-time":"2018-08-20T13:23:42Z","timestamp":1534771422000},"page":"177-183","source":"Crossref","is-referenced-by-count":10,"title":["Podocituria en pacientes pedi\u00e1tricos con enfermedad de Fabry"],"prefix":"10.1016","volume":"39","author":[{"given":"Miguel","family":"Liern","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anabella","family":"Collazo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maylin","family":"Valencia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alejandro","family":"Fainboin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorena","family":"Isse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristian","family":"Costales-Collaguazo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Federico","family":"Ochoa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Graciela","family":"Vallejo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elsa","family":"Zotta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.nefro.2018.05.009_bib0110","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1097\/00041552-200503000-00002","article-title":"Fabry disease: Diagnosis and management, with emphasis on the renal manifestations","volume":"14","author":"Warnock","year":"2005","journal-title":"Curr Opin Nephrol Hyperten"},{"key":"10.1016\/j.nefro.2018.05.009_bib0115","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1097\/00005792-200203000-00003","article-title":"Natural history of Fabry renal disease. Influence of galactosidase A activity and genetic mutations on clinical course","volume":"81","author":"Branton","year":"2002","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.nefro.2018.05.009_bib0120","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/ncpneph0806","article-title":"Recommendations and guidelines for the diagnosis and treatment of Fabry nephropathy in adults","volume":"4","author":"Ortiz","year":"2008","journal-title":"Nat Clin Pract Nephrol"},{"key":"10.1016\/j.nefro.2018.05.009_bib0125","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1083\/jcb.60.2.423","article-title":"Porous substructure of the glomerular slit diaphragm in the rat and mouse","volume":"60","author":"Rodewald","year":"1974","journal-title":"J Cell Biol"},{"key":"10.1016\/j.nefro.2018.05.009_bib0130","first-page":"S87","article-title":"Why is proteinuria such an important risk factor for progression in clinical trials?","volume":"63","author":"Jerums","year":"1997","journal-title":"Kidney Int Suppl"},{"key":"10.1016\/j.nefro.2018.05.009_bib0135","first-page":"85","article-title":"Podocyturia without proteinuria and with normal renal function in a young adult with Fabry disease","volume":"14","author":"Trimarchi","year":"2016","journal-title":"Rev Nefr Arg"},{"key":"10.1016\/j.nefro.2018.05.009_bib0140","doi-asserted-by":"crossref","first-page":"F40","DOI":"10.1152\/ajprenal.00404.2002","article-title":"Urinary excretion of viable podocytes in health and renal disease","volume":"285","author":"Vogelmann","year":"2003","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.nefro.2018.05.009_bib0145","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1007\/s00467-016-3387-4","article-title":"Significant improvement in Fabry disease podocytopathy after 3 years of treatment with agalsidase beta","volume":"31","author":"Shuichi","year":"2016","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.nefro.2018.05.009_bib0150","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/j.jpeds.2010.02.012","article-title":"Misdiagnosis in Fabry disease","volume":"156","author":"Marchesoni","year":"2010","journal-title":"J Pediatr"},{"key":"10.1016\/j.nefro.2018.05.009_bib0155","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/8904_2011_14","article-title":"Foot process effacement with normal urinalysis in classic Fabry disease","volume":"1","author":"Kanai","year":"2011","journal-title":"JIMD Rep"},{"key":"10.1016\/j.nefro.2018.05.009_bib0160","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1097\/MNH.0b013e32832c9dba","article-title":"Glomerular filtration barrier","volume":"18","author":"Haraldsson","year":"2009","journal-title":"Curr Opin Nephrol Hypertens."},{"key":"10.1016\/j.nefro.2018.05.009_bib0165","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1097\/01.ASN.0000130167.30769.55","article-title":"Signaling at the slit diaphragm","volume":"15","author":"Benzing","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.nefro.2018.05.009_bib0170","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1172\/JCI200523371","article-title":"Synaptopodin regulates the actin-bundling activity of alpha-actinin in an isoform-specific manner","volume":"115","author":"Asanuma","year":"2005","journal-title":"J Clin Invest."},{"key":"10.1016\/j.nefro.2018.05.009_bib0175","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1177\/002215540305101203","article-title":"Actin filament organization of foot process in rat podocytes","volume":"51","author":"Ichimura","year":"2003","journal-title":"J Histochem Cytochem."},{"key":"10.1016\/j.nefro.2018.05.009_bib0180","doi-asserted-by":"crossref","first-page":"152","DOI":"10.5812\/nephropathol.8110","article-title":"Is it or is it not a pathogenic mutation? Is it or is it not the podocyte?","volume":"1","author":"Sanchez-Ni\u00f1o","year":"2012","journal-title":"J Nephropathology."},{"key":"10.1016\/j.nefro.2018.05.009_bib0185","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1097\/01.gim.0000237866.70357.c6","article-title":"Fabry disease: Guidelines for the evaluation and management of multi-organ system involvement","volume":"8","author":"Eng","year":"2006","journal-title":"Genet Med"},{"key":"10.1016\/j.nefro.2018.05.009_bib0190","article-title":"Foot process effacement is an early marker of nephropathy in young classic Fabry patients without albuminuria","author":"Tondel","year":"2014","journal-title":"Nephron"},{"key":"10.1016\/j.nefro.2018.05.009_bib0195","unstructured":"Trimarchi H, Canzonieri R, Zotta E. Podocyturia is significantly elevated in untreated vs treated Fabry adult patients. J Nephrol. DOI 10.1007\/s40620-016-0271-z"},{"key":"10.1016\/j.nefro.2018.05.009_bib0200","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.ymgme.2010.06.002","article-title":"Age adjusting severity scores for Anderson-Fabry disease","volume":"101","author":"Hughes","year":"2010","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.nefro.2018.05.009_bib0205","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1053\/j.ajkd.2014.08.016","article-title":"Viable podocyturia in healthy individuals: Implications for podocytopathies","volume":"64","author":"Maestroni","year":"2014","journal-title":"Am J Kidney Dis."},{"key":"10.1016\/j.nefro.2018.05.009_bib0210","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1093\/ndt\/gfs526","article-title":"Fabry nephropathy: Indications for screening and guidance for diagnosis and treatment by the European Renal Best Practice","volume":"28","author":"Terryn","year":"2013","journal-title":"Nephrol Dial Transplant"}],"container-title":["Nefrolog\u00eda"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0211699518301103?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0211699518301103?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,10,22]],"date-time":"2019-10-22T16:20:22Z","timestamp":1571761222000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0211699518301103"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":21,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["S0211699518301103"],"URL":"https:\/\/doi.org\/10.1016\/j.nefro.2018.05.009","relation":{},"ISSN":["0211-6995"],"issn-type":[{"value":"0211-6995","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]}}}